** Shares of diabetes care company MiniMed MMED.O rise 4.7% to $12.88 premarket

** MMED posts Q4 net sales of $837 mln, above analysts' estimates of $827.3 mln - data compiled by LSEG

** Reports 2026 sales of $3.1 bln, above analysts' estimates of $3.08 bln

** Expects organic revenue growth of about 10% for fiscal year 2027

** Analysts on an average expect 2027 revenue to be $3.4 bln

** Up to last close, stock is down 33.5% since its IPO in March